ASIMADOLINE
- Product Name
- ASIMADOLINE
- CAS No.
- 153205-46-0
- Chemical Name
- ASIMADOLINE
- Synonyms
- EMD 61753;ASIMADOLINE;Asimadoline (EMD-61753;EMD-61753;EMD61753;EMD 61753;N-((S)-2-((S)-3-Hydroxypyrrolidin-1-yl)-1-phenylethyl)-N-methyl-2,2-diphenylacetamide;Benzeneacetamide, N-[(1S)-2-[(3S)-3-hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-α-phenyl-;N-[(1S)-2-[(3S)-3-Hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-alpha-phenylbenzeneacetamide
- CBNumber
- CB6228855
- Molecular Formula
- C27H30N2O2
- Formula Weight
- 414.54
- MOL File
- 153205-46-0.mol
ASIMADOLINE Property
- Boiling point:
- 605.8±55.0 °C(Predicted)
- Density
- 1.170±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: 103 mg/ml
- form
- A crystalline solid
- pka
- 14.79±0.20(Predicted)
N-Bromosuccinimide Price
- Product number
- 26411
- Product name
- Asimadoline
- Packaging
- 5mg
- Price
- $109
- Updated
- 2024/03/01
- Product number
- 26411
- Product name
- Asimadoline
- Packaging
- 25mg
- Price
- $420
- Updated
- 2024/03/01
- Product number
- 26411
- Product name
- Asimadoline
- Packaging
- 1mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 26411
- Product name
- Asimadoline
- Packaging
- 10mg
- Price
- $199
- Updated
- 2024/03/01
- Product number
- CS-8053
- Product name
- Asimadoline
- Purity
- 99.36%
- Packaging
- 10mg
- Price
- $156
- Updated
- 2021/12/16
ASIMADOLINE Chemical Properties,Usage,Production
Uses
Acimadolin is a K-opioid agonist that raises the sensitivity threshold in patients with irritable bowel syndrome (IBS), barely crosses the blood-brain barrier, and is well tolerated. It cannot significantly improve the pain threshold of patients, Can significantly reduce pain intensity.
Biological Activity
Asimadoline (EMD-61753) is an orally active, selective, peripherally active κ-opioid agonist with IC50s of 5.6 nM and 1.2 nM for guinea pig and human recombinant κ-opioid, respectively. It has low permeability to the blood-brain barrier and has peripheral anti-inflammatory effects. Also Asimadoline improves allodynia in diabetic rats and has potential for irritable bowel syndrome (IBS) research.
in vitro
Asimadoline (EMD-61753) has high selectively in κ: μ: δ opioid binding ratios of 1:501:498 in human recombinant receptors. The IC 50 for Asimadoline binding to μ -opioid receptors is 3 μM and to δ-opioid receptors is 0.7 μM. The IC 50 values for D1, D2, kainate, σ, PCP/NMDA, H1, α1, α2, M1/M2, glycine, 5HT1A, 5HT1C, 5HT1D, 5HT2, 5HT3, AMPA and kainate/AMPA receptors are all >10 μM.
It has affinity to sodium and L type Ca 2+ ion channels at IC 50 concentrations 150 to 800 fold the IC 50 for the κ receptors.
At high concentrations, Asimadoline demonstrates spasmolytic action against 400 μM barium chloride in the rat duodenum (IC 50 =4.2 μM), suggesting that Asimadoline may block the direct stimulant effects of barium on smooth muscle through mechanisms that are not identified.
in vivo
Asimadoline (EMD-61753; 1, 5, 15 mg/kg; sc) acutely ameliorates both formalin-evoked hyperalgesia and tactile allodynia in diabetic rats.
The absorption rate following oral administration is 80% in rats and >90% in dogs and monkeys. The metabolism of Asimadoline is rapid and appears similar in animals and man. Asimadoline has peripheral anti-inflammatory actions that are partly mediated through increase in joint fluid substance P levels.
target
IC50: 5.6 nM (guinea pig κ opioid), 1.2 nM (human recombinant κ opioid)